Oct 20 (Reuters) - AbbVie ( ABBV ) said on Monday its
newer arthritis drug Rinvoq showed superiority over the
company's previous bestseller Humira, meeting the main goal of a
head-to-head trial.
(Reporting by Puyaan Singh in Bengaluru)